Amir Inamdar

Interventional psychiatry is advancing rapidly, but commercializing new treatments in this space requires navigating scientific complexity, clinical workflow integration, regulatory ambiguity and evolving payer expectations. This workshop brings together leaders across drug development, clinical services, digital therapeutics and health system innovation to unpack what it takes to bring interventional psychiatric treatments to market effectively and responsibly. Through real world case studies and cross sector perspectives, attendees will explore how to position novel modalities, build scalable delivery models, integrate biomarkers and patient selection tools, evaluate reimbursement pathways, and ensure safe, consistent implementation across diverse clinical environments.

• Define the commercial, clinical and operational considerations required to bring interventional psychiatric treatments to market, including positioning, differentiation and workflow integration
• Examine the infrastructure, training, safety and scalability requirements needed for real world delivery across clinics, health systems and community based care settings
• Identify viable reimbursement and market access pathways by understanding payer priorities, value demonstration, and the evidence needed to support sustainable adoption